Delivering mitochondrial health
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023. CEO Ellen Donnelly will be presenting the company in BioStock's studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.
In April, we will attend this year's Kempen Life Science Conference in Amsterdam, Netherlands.
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today." CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches […]
On May 25, Abliva will participate at Erik Penser Bank's Penser Market Bolagsdag in Stockholm. Abliva's CMO, Magnus Hansson, will be presenting the company during the morning session. Further details and link to event below.
In late May, Abliva will attend and present at ABG Sundal Collier's Life Science Summit Seminar in Stockholm, Sweden. The event will also be live-streamed. See below for more info.
Our Chief Medical Officer, Magus Hansson, will give a talk at Penser South Company Day in Malmö, on September 14, 2023. Click the link below for more details and registration.
In late October, Abliva will attend the BioStock's Life Science Summit at Medicon Village in Lund. Magnus Hansson, Abliva's Chief Medical Officer, will be presenting the company at 09:05 a.m. CET on October 25. See more details and the link to the event below.
In October, Abliva's CEO, Ellen Donnelly, will attend Hadean Venture's annual event in Oslo.
This fall, Abliva's CEO, Ellen Donnelly will attend the two connected events LSX Inv€$tival Showcase and Jefferies London Healthcare Conference. On November 13 at 11:45 a.m., the Abliva's CEO, Ellen Donnelly, will present the company at LSX Inv€$tival Showcase. See the link below for more details.
In late November, Abliva will attend Nordic Life Science Days, at Bella Center in Copenhagen, Denmark. CEO Ellen Donnelly will be presenting the company during the session Biotechnology - Therapeutics & Diagnostics on November 29 at 2:12 p.m. CET in Auditorium 10. Follow the link below for more details.
In early January 2024, Abliva's CEO, Ellen Donnelly, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA. The conference is a healthcare investment symposium that connects global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Follow the link below to learn more.
In mid-April, Abliva will participate at Kempen Life Sciences Conference in Amsterdam, The Netherlands. For more information, please click the link below.